SMN1 and amyotrophic lateral sclerosis: Based on this knowledge, more extensive studies on animal models and humans are needed to better understand the involvement of myomiRs in muscle remodeling in ALS, SMA, and SBMA during disease progression, and their potential as molecular targets of effective treatments for these conditions.